Literature DB >> 25526981

Association between rs1344706 of ZNF804A and schizophrenia: a meta-analysis.

Meiyan Zhu1, Tongyang Liu1, Jihong Zhang1, Shuting Jia1, Wenru Tang2, Ying Luo3.   

Abstract

Schizophrenia is one of the most serious mental diseases found in humans. Previous studies indicated that the single nucleotide polymorphism (SNP) rs1344706 in the gene ZNF804A encoding zinc finger protein 804A was associated with schizophrenia in Caucasian population but not in Chinese Han population. However, current results are conflicting in Asian population. In the present study, a meta-analysis was performed to revisit the association between rs1344706 and the risk of schizophrenia in Asian, Caucasian and other populations. Electronic search of PubMed database identified 25 case-control studies with available genotype frequencies of rs1344706 for the meta-analysis, involving a total of 15,788 cases and 22,654 controls. A pooled odds ratio (OR) with 95% confidence interval (CI) was used to assess the association. The current meta-analysis showed an association between rs1344706 and schizophrenia in Caucasian populations (P=0.028, OR=1.138, 95% CI: 1.014-1.278; P=0.004 for heterogeneity) and Asian populations (P=0.008, OR=1.092, 95% CI: 1.023-1.165; P=0.001 for heterogeneity), but not in other populations (P=0.286, OR=1.209, 95% CI: 0.853-1.714, P=0.120 for heterogeneity). Egger's test (P>0.05) and Begg's test (P>0.05) are both suggestive of the lack of publication bias for the included studies. Thus, the absence of association in other populations suggests a genetic heterogeneity in the susceptibility of schizophrenia and demonstrates the difficulties in replicating genome-wide association study findings regarding schizophrenia across different ethnic populations. To validate the association between rs1344706 and schizophrenia, further studies with larger participant populations worldwide are needed.
Copyright © 2014. Production and hosting by Elsevier Ltd.

Entities:  

Keywords:  Asians; Association; Caucasians; Meta-analysis; Schizophrenia; ZNF804A

Mesh:

Substances:

Year:  2014        PMID: 25526981      PMCID: PMC4411477          DOI: 10.1016/j.gpb.2014.10.005

Source DB:  PubMed          Journal:  Genomics Proteomics Bioinformatics        ISSN: 1672-0229            Impact factor:   7.691


Introduction

Schizophrenia is a common, serious psychotic disorder. The main features of schizophrenia include various psychotic symptoms such as delusions, auditory hallucinations, altered emotional reactivity, disorganized behavior, social isolation and cognitive impairment [1]. Many studies based on families, twins and adopted individuals have consistently demonstrated the importance of genetic factors and of the combination of environmental and genetic factors to the etiology of schizophrenia, among which heritability estimates are approximately 80% [2-4]. Genetic variants in the gene ZNF804A have been found to be associated with schizophrenia in a genome-wide association study (GWAS) [5]. In particular, the intronic single nucleotide polymorphism (SNP) rs1344706 (A/C) has been associated with schizophrenia in several studies, with the A allele being the risk allele [5-8]. ZNF804A (OMIM: 612282) is located on chromosome 2q32.1 and consists of 4 exons and 3 introns [6]. ZNF804A encodes zinc finger protein 804A, which contains a C2H2-type zinc finger domain, and is distributed throughout the human brain especially in the developing medial temporal lobe and brain cortices [9-11]. Proteins with zinc finger domains play a variety of roles, including binding to DNA, transcriptional regulation, gene expression and DNA–protein interactions [10,12,13]. However, the exact functions of ZNF804A remain unknown [11]. Some studies suggested that rs1344706 may be associated with brain structure and function [14-16]. To further explore whether the risk allele A of rs1344706 would increase the risk of schizophrenia in different populations, the present meta-analysis was performed to evaluate the association between rs1344706 and the risk of schizophrenia in Asian, Caucasian and other populations.

Results

Eligible studies

A total of 25 studies that reported the association between rs1344706 and schizophrenia were identified from the literature and included in this meta-analysis (Figure 1), including 15,788 schizophrenia cases and 22,654 controls. The detailed characteristics of eligible studies are summarized in Table 1.
Figure 1

Forest plot of association between rs1344706 and schizophrenia in different ethnic populations

Forest plot of odds ratio (OR) of schizophrenia A allele when compared to the C allele (additive model) was generated. The OR of each study was plotted. The vertical black line indicates that OR equals to 1 and the dashed line in red indicates the overall OR for all 25 studies. The solid diamond and horizontal line correspond to the study-specific OR and 95% CI of each individual study, respectively. The area of the gray box reflects the study-specific weight, which was calculated from random effects analysis. The open diamond represents the pooled OR and 95% CI. The studies included in the meta analysis are listed according to the time of publication.

Table 1

Characteristics of the 25 studies included in the current meta-analysis

PopulationCountryYear of publicationNumber of casesNumber of controlsA allele frequency (%)
AuthorsRefs.
CaseControl
AsianChina200899610150.5300.514O’Donovan[5]
AsianChina20104394460.5330.546Steinberg[7]
AsianJapan20101131840.5880.530Hashimoto[17]
AsianChina20114964480.6010.536Xiao[18]
AsianChina2011361763440.4960.503Shi[19]
AsianChina201189112980.5030.509Li[20]
AsianChina20115665740.5270.457Zhang[21]
AsianSingapore20128859760.5200.506Li[22]
AsianChina20125227930.5120.501Liou[1]
AsianChina2012111670.5270.560Kuswanto[23]
AsianChina20125704480.5640.508Chen[24]
AsianIndonesia2013106711110.5250.489Schwab[25]
AsianChina201310249750.5380.510Yang[26]
CaucasianUK200864229370.6600.590O’Donovan[5]
CaucasianGermany201025114720.5880.588Walters[27]
CaucasianIreland20102971650.6650.603Walters[8]
CaucasianIreland201010216260.6500.610Riley[6]
CaucasianGermany20119365850.6200.610Schanze[28]
CaucasianItaly201170380.6000.684Donohoe[29]
CaucasianUK201147914450.6700.590Williams[8]
CaucasianRomania20122312220.6360.651Zaharie[30]
CaucasianUK201284830.6550.608Sporooten[31]
CaucasianIreland201430670.5830.679O’Donoghue[32]
OtherUSA20123351980.6220.614Wassink[33]
OtherTurkey20121051370.6760.584Sazci[34]

Note: Other populations include Turkish [34] and American [33].

Meta analysis

The evaluation of the association between rs1344706 and the heterogeneity test is shown in Table 2. Since the genetic polymorphism model of ZNF804A is unclear, we used the additive model (A allele vs. C allele) for analysis. Our data showed an association with risk of schizophrenia in Caucasian populations (P = 0.028, OR = 1.138, 95% CI: 1.014–1.278; P = 0.004 for heterogeneity) and Asian populations (P = 0.008, OR = 1.092, 95% CI: 1.023–1.165; P = 0.001 for heterogeneity), but not in other populations (P = 0.286, OR = 1.209, 95% CI: 0.853–1.714, P = 0.120 for heterogeneity) (Figure 1).
Table 2

Meta-analysis of the association between rs1344706 and schizophrenia in different ethnic populations

PopulationPooled OR (95% CI)P valueHeterogeneity P valuePublication bias P value
Begg’s testEgger’s test
Asian1.092 (1.023, 1.165)0.0080.0010.4640.058
Caucasian1.138 (1.014, 1.278)0.0280.0040.3250.096
Others1.209 (0.853, 1.714)0.2860.1200.317NA
Overall1.117 (1.053, 1.185)0.000<0.0010.9200.695

Note: NA, not applicable.

Publication bias

The main purpose of meta-analysis is to extract information from published studies. However, selective publication of studies in a meta-analysis could lead to bias in the conclusions [35,36]. Therefore, Egger’s test and Begg’s test were performed to evaluate whether there exists publication bias in the previous studies on schizophrenia selected for this meta-analysis. As shown in Table 2, the P values from Egger’s test and Begg’s test for publication bias were in the range 0.058–0.92, which are all above the significance threshold. These data indicate no publication bias (P > 0.05 for both) for the studies included for the meta-analysis, which is further evidenced by the symmetry of the funnel plot as shown in Figure 2.
Figure 2

Begg’s funnel plot for meta-analysis of rs1344706

The funnel plot is a scatter plot testing publication bias by determining if there is a significant correlation between the estimated effect sizes and their variances. The funnel graph plots log OR vs. their standard error. The horizontal line in the funnel plot indicates the summary estimate, while the sloping lines indicate the expected 95% CI for a given standard error, assuming no heterogeneity between studies. The statistical analysis was performed with pseudo 95% confidence limits using Stata software.

Discussion

Several SNPs such as rs1344706, rs4667001 and rs728534 in ZNF804A have been associated with schizophrenia in a GWAS of European population in 2008 [5]. Later on, three independent laboratories also demonstrated that rs1344706 in ZNF804A was associated with schizophrenia in European populations [37-39]. However, a previous meta-analysis suggested that rs1344706 is not associated with schizophrenia in Chinese Han population [40]. Thus, further studies are necessary to explore whether the risk allele A of rs1344706 would increase the risk of schizophrenia in different populations. Our present meta-analysis showed that rs1344706 is associated with schizophrenia in both Caucasian (P = 0.028) and Asian populations (P = 0.008), but not in other populations (P = 0.286). Two studies were classified as “others”, including one performed by Wassink et al. in the United States [33] since the components of the study population were not described in the report. The other study is on Turkish population [34], since we cannot determine whether Turkish belongs to Asian population or Caucasian population. Our data agree well with the reported association of rs1344706 with the Caucasian. Nonetheless, these data are inconsistent with the previous study in Chinese populations. Such discrepancy could be explained by the number of studies included for Asian populations. In their report, Li et al. [40] included 8 studies (8982 cases and 12,342 controls) while we have 13 studies (11,297 cases and 14,679 controls) in the present meta-analysis, which included not only Chinese population but also other Asian populations like Japanese, Singaporeans and Indonesian. The difference in association of rs1344706 with schizophrenia between Caucasian, Asian and other populations may be due to the genetic heterogeneity of different ethnic populations [26]. The current findings suggest that genetic associations observed in complex psychiatric disorders may not be generalizable to different populations. Several studies have suggested that intelligence quotient (IQ) may modulate the association between ZNF804A gene polymorphism and cognitive function in schizophrenia patients [24,27]. Therefore, IQ may be a confounding factor and may modulate the association between rs1344706 and schizophrenia in other populations, which might explain our failure to find a significant association between rs1344706 and schizophrenia in other populations. Further association studies with more patients from more ethnic background would be required to determine the details.

Materials and methods

Literature search

The PubMed database was surveyed using search terms “ZNF804A”, “SNP” and “schizophrenia” (the last search update was on May 14, 2014). Case–control studies with genotype frequencies of rs1344706 available were chosen without language restrictions. Additional studies were identified using review articles and manual searches of the reference section of original studies.

Statistical analysis

The strength of association between rs1344706 and schizophrenia was assessed by calculating crude additive ORs and 95% CIs for each study. The pooled ORs were calculated based on an additive genetic model (A allele vs. C allele). Due to the significant heterogeneity observed between studies (P = 0.001 for heterogeneity in Asian, and P = 0.004 for heterogeneity in Caucasian), the random effects model was used to calculate the pooled ORs. Publication bias was examined using Begg’s test rank correlation method (funnel plot method) and Egger’s weighted regression method (P < 0.05 was considered significant) [35,36]. All statistical analyses were performed using Stata software (version 9.0; STATA Corporation, College Station, TX).

Authors’ contributions

YL and WT conceived the idea and participated in study design. TL and JZ were involved in the study design. MZ carried out electronic search of PubMed database, performed the statistical analysis and drafted the manuscript. SJ, YL and WT revised the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that there are no competing interests.
  40 in total

Review 1.  Sticky fingers: zinc-fingers as protein-recognition motifs.

Authors:  Roland Gamsjaeger; Chu Kong Liew; Fionna E Loughlin; Merlin Crossley; Joel P Mackay
Journal:  Trends Biochem Sci       Date:  2007-01-08       Impact factor: 13.807

2.  Identification of loci associated with schizophrenia by genome-wide association and follow-up.

Authors:  Michael C O'Donovan; Nicholas Craddock; Nadine Norton; Hywel Williams; Timothy Peirce; Valentina Moskvina; Ivan Nikolov; Marian Hamshere; Liam Carroll; Lyudmila Georgieva; Sarah Dwyer; Peter Holmans; Jonathan L Marchini; Chris C A Spencer; Bryan Howie; Hin-Tak Leung; Annette M Hartmann; Hans-Jürgen Möller; Derek W Morris; Yongyong Shi; GuoYin Feng; Per Hoffmann; Peter Propping; Catalina Vasilescu; Wolfgang Maier; Marcella Rietschel; Stanley Zammit; Johannes Schumacher; Emma M Quinn; Thomas G Schulze; Nigel M Williams; Ina Giegling; Nakao Iwata; Masashi Ikeda; Ariel Darvasi; Sagiv Shifman; Lin He; Jubao Duan; Alan R Sanders; Douglas F Levinson; Pablo V Gejman; Sven Cichon; Markus M Nöthen; Michael Gill; Aiden Corvin; Dan Rujescu; George Kirov; Michael J Owen; Nancy G Buccola; Bryan J Mowry; Robert Freedman; Farooq Amin; Donald W Black; Jeremy M Silverman; William F Byerley; C Robert Cloninger
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

3.  Bias in meta-analysis detected by a simple, graphical test.

Authors:  M Egger; G Davey Smith; M Schneider; C Minder
Journal:  BMJ       Date:  1997-09-13

4.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

Review 5.  Predictors of schizophrenia--a review.

Authors:  Pirjo Mäki; Juha Veijola; Peter B Jones; Graham K Murray; Hannu Koponen; Pekka Tienari; Jouko Miettunen; Päivikki Tanskanen; Karl-Erik Wahlberg; Johanna Koskinen; Erika Lauronen; Matti Isohanni
Journal:  Br Med Bull       Date:  2005-06-09       Impact factor: 4.291

6.  Neural mechanisms of a genome-wide supported psychosis variant.

Authors:  Christine Esslinger; Henrik Walter; Peter Kirsch; Susanne Erk; Knut Schnell; Claudia Arnold; Leila Haddad; Daniela Mier; Carola Opitz von Boberfeld; Kyeon Raab; Stephanie H Witt; Marcella Rietschel; Sven Cichon; Andreas Meyer-Lindenberg
Journal:  Science       Date:  2009-05-01       Impact factor: 47.728

7.  Functional and evolutionary insights into human brain development through global transcriptome analysis.

Authors:  Matthew B Johnson; Yuka Imamura Kawasawa; Christopher E Mason; Zeljka Krsnik; Giovanni Coppola; Darko Bogdanović; Daniel H Geschwind; Shrikant M Mane; Matthew W State; Nenad Sestan
Journal:  Neuron       Date:  2009-05-28       Impact factor: 17.173

8.  Evaluation of the relationship between the ZNF804A single nucleotide polymorphism rs1344706 A/C variant and schizophrenia subtype in Han Chinese patients.

Authors:  Yongfeng Yang; Wenqiang Li; Ge Yang; Bo Xiao; Xiujuan Wang; Minli Ding; Jingyuan Zhao; Xueqing Song; Weihua Yue; Dai Zhang; Hongxing Zhang; Luxian Lv
Journal:  Int J Psychiatry Med       Date:  2013       Impact factor: 1.210

9.  Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study.

Authors:  Paul Lichtenstein; Benjamin H Yip; Camilla Björk; Yudi Pawitan; Tyrone D Cannon; Patrick F Sullivan; Christina M Hultman
Journal:  Lancet       Date:  2009-01-17       Impact factor: 79.321

10.  Effects of ZNF804A on auditory P300 response in schizophrenia.

Authors:  T O'Donoghue; D W Morris; C Fahey; A Da Costa; S Moore; E Cummings; G Leicht; S Karch; D Hoerold; D Tropea; J J Foxe; M Gill; A Corvin; G Donohoe
Journal:  Transl Psychiatry       Date:  2014-01-14       Impact factor: 6.222

View more
  5 in total

1.  Theory of mind network activity is altered in subjects with familial liability for schizophrenia.

Authors:  Sebastian Mohnke; Susanne Erk; Knut Schnell; Nina Romanczuk-Seiferth; Phöbe Schmierer; Lydia Romund; Maria Garbusow; Carolin Wackerhagen; Stephan Ripke; Oliver Grimm; Leila Haller; Stephanie H Witt; Franziska Degenhardt; Heike Tost; Andreas Heinz; Andreas Meyer-Lindenberg; Henrik Walter
Journal:  Soc Cogn Affect Neurosci       Date:  2015-09-04       Impact factor: 3.436

2.  Molecular anatomy of the thalamic complex and the underlying transcription factors.

Authors:  Andrzej Nagalski; Luis Puelles; Michal Dabrowski; Tomasz Wegierski; Jacek Kuznicki; Marta B Wisniewska
Journal:  Brain Struct Funct       Date:  2015-05-12       Impact factor: 3.270

Review 3.  Genetic Consideration of Schizotypal Traits: A Review.

Authors:  Emma E Walter; Francesca Fernandez; Mollie Snelling; Emma Barkus
Journal:  Front Psychol       Date:  2016-11-15

4.  Analyzing a single nucleotide polymorphism in schizophrenia: a meta-analysis approach.

Authors:  Oluwadamilare Falola; Victor Chukwudi Osamor; Marion Adebiyi; Ezekiel Adebiyi
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-23       Impact factor: 2.570

5.  Data on association of the variation (rs1344706) in the ZNF804A gene with schizophrenia and its symptoms in the Russian population.

Authors:  T V Lezheiko; D V Romanov; N Yu Kolesina; V E Golimbet
Journal:  Data Brief       Date:  2019-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.